Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1954 1
1981 1
1982 1
1983 2
1984 5
1985 2
1986 3
1987 2
1988 5
1990 4
1991 2
1992 1
1994 1
1995 2
1996 3
1997 2
1998 2
1999 3
2000 1
2002 4
2003 4
2004 4
2005 4
2006 1
2007 1
2008 1
2009 2
2010 2
2012 2
2013 2
2014 2
2015 3
2016 1
2017 5
2018 4
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Dreano E, Burgel PR, Hatton A, Bouazza N, Chevalier B, Macey J, Leroy S, Durieu I, Weiss L, Grenet D, Stremler N, Ohlmann C, Reix P, Porzio M, Roux Claude P, Rémus N, Douvry B, Montcouquiol S, Cosson L, Mankikian J, Languepin J, Houdouin V, Le Clainche L, Guillaumot A, Pouradier D, Tissot A, Priou P, Mély L, Chedevergne F, Lebourgeois M, Lebihan J, Martin C, Zavala F, Da Silva J, Lemonnier L, Kelly-Aubert M, Golec A, Foucaud P, Marguet C, Edelman A, Hinzpeter A, de Carli P, Girodon E, Sermet-Gaudelus I, Pranke I; French CF Reference Network study group. Dreano E, et al. Among authors: foucaud p. Eur Respir J. 2023 Oct 19;62(4):2300110. doi: 10.1183/13993003.00110-2023. Print 2023 Oct. Eur Respir J. 2023. PMID: 37696564
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Burgel PR, Sermet-Gaudelus I, Durieu I, Kanaan R, Macey J, Grenet D, Porzio M, Coolen-Allou N, Chiron R, Marguet C, Douvry B, Dufeu N, Danner-Boucher I, Foucaud P, Lemonnier L, Girodon E, Da Silva J, Martin C; French CF Reference Network study group. Burgel PR, et al. Among authors: foucaud p. Eur Respir J. 2023 Feb 16:2202437. doi: 10.1183/13993003.02437-2022. Online ahead of print. Eur Respir J. 2023. PMID: 36796836
[Streptococcus pyogenes an emerging pathogen].
Cohen R, Aujard Y, Bidet P, Bourrillon A, Bingen E, Foucaud P, François M, Garnier JM, Gendrel D, Guillot M, Hau I, Olivier C, Quinet B, Raymond J. Cohen R, et al. Among authors: foucaud p. Arch Pediatr. 2005 Jul;12(7):1065-7. doi: 10.1016/j.arcped.2005.01.021. Arch Pediatr. 2005. PMID: 15913971 Review. French. No abstract available.
[Vivre avec la mucoviscidose].
Foucaud P. Foucaud P. Rev Prat. 2022 Jun;72(6):653-655. Rev Prat. 2022. PMID: 35899672 French. No abstract available.
Photo quiz: multiple skin lesions on a 9-year-old boy returning from Mali.
Farfour E, Badell E, Jacques Natali L, Dommergues MA, Blot S, Guiso N, Pangon B, Foucaud P. Farfour E, et al. Among authors: foucaud p. J Clin Microbiol. 2014 Oct;52(10):3523; discussion 3832-3. doi: 10.1128/JCM.00779-13. J Clin Microbiol. 2014. PMID: 25227615 Free PMC article. No abstract available.
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Burgel PR, Sermet-Gaudelus I, Girodon E, Durieu I, Houdouin V, Audousset C, Macey J, Grenet D, Porzio M, Murris-Espin M, Reix P, Baravalle M, Belleguic C, Mely L, Verhille J, Weiss L, Reynaud-Gaubert M, Mittaine M, Hamidfar R, Ramel S, Cosson L, Douvry B, Danner-Boucher I, Foucaud P, Roy C, Burnet E, Raynal C, Audrezet MP, Da Silva J, Martin C; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Among authors: foucaud p. Lancet Respir Med. 2024 Aug 13:S2213-2600(24)00208-X. doi: 10.1016/S2213-2600(24)00208-X. Online ahead of print. Lancet Respir Med. 2024. PMID: 39151434
[Therapeutic approaches in children immunized with vaccine Prevenar].
Cohen R, Aujard Y, Bingen E, Boucherat M, Bourrillon A, Foucaud P, Francois M, Garnier JM, Guillot M, Ovetchkine P, Ployet MJ, Quinet B, Gaudelus J. Cohen R, et al. Among authors: foucaud p. Arch Pediatr. 2002 Jan;9(1):4-6. doi: 10.1016/s0929-693x(01)00686-8. Arch Pediatr. 2002. PMID: 11865548 French. No abstract available.
89 results